CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 151 enrolled
Drug / intervention
S.M.A.R.T. RADIANZ™ Vascular Stent System +2 moredevice
Likely dose
S.M.A.R.T. RADIANZ™ Vascular Stent System delivered via 6F (2.0 mm) transradial approach; up to 2 stents per lesion; BRITE TIP RADIANZ™ guiding sheath and SABERX RADIANZ™ PTA balloon catheter as adjunctsAI-extracted
Key inclusion· 7
  • Age ≥18 years
  • Symptomatic leg ischemia or ischemic ulcerations not exceeding foot digits (Rutherford/Becker Classification 2, 3, 4, or 5)
  • Palpable radial artery with diameter ≥2.5 mm confirmed by duplex ultrasound
  • For iliac lesions: single de novo or restenotic lesion ≥50% stenosis in common and/or external iliac artery, ≤100 mm length, treatable with ≤2 stents, RVD 4.0–9.0 mm, patent profunda or SFA
Key exclusion· 25
  • Any prior intervention to target vessel within 90 days (graft, stroke, cryoplasty, laser, atherectomy, aneurysm)
  • Previously deployed stent at target lesion site
  • Post-surgical stenosis or anastomotic suture treatments of target vessel
  • Requires general anesthesia for procedure

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05399680
NCT05399680N/ACompleted

Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access

Cordis US Corp.·interventional·Posted Jun 1, 2022·Updated Aug 11, 2025

In Brief

A clinical study evaluating S.M.A.R.T. RADIANZ™ Vascular Stent System, BRITE TIP RADIANZ™ Guiding Sheath, and 1 other intervention for Peripheral Arterial Disease. Completed, enrolled 151 participants across 12 sites in 6 countries.

Detailed Summary

The primary objective of this clinical investigation was to evaluate acute safety and efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System, when used with the BRITE TIP RADIANZ™ Guiding Sheath and SABERX RADIANZ™ PTA Balloon Catheter, to deploy the S.M.A.R.T.™ Nitinol Stent, in the treatment of patients with obstructive iliac or femoropopliteal arterial disease via radial artery access.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustria, Belgium, France, Italy, Spain, Switzerland
CollaboratorsQserve, NAMSA

Timeline

N/ACompletedFinished
2023202420252026
First PostedJun 1, 2022
Enrollment StartJun 29, 2022
Primary CompletionSep 22, 2023
Study CompletionNov 13, 2023
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 4.1 years ago

Interventions

S.M.A.R.T. RADIANZ™ Vascular Stent Systemdevice

The S.M.A.R.T. RADIANZ™ Vascular Stent System is designed to deliver the S.M.A.R.T.™ self-expanding stent (S.M.A.R.T.™ stent) to the iliac arteries, superficial femoral arteries and/or proximal popliteal arteries using a 6F (2.0 mm) sheathed delivery system introduced through the radial artery.

BRITE TIP RADIANZ™ Guiding Sheathdevice

BRITE TIP RADIANZ™ is a catheter guiding sheath that facilitates percutaneous entry of an intravascular device into the peripheral vasculature through the radial artery.

SABERX RADIANZ™ PTA Balloon Catheterdevice

SABERX RADIANZ™ is a catheter with a distal inflatable balloon.